Madrigal Pharmaceuticals ... (MDGL)
315.10
-26.17 (-7.67%)
At close: Mar 03, 2025, 3:59 PM
313.47
-0.52%
After-hours: Mar 03, 2025, 04:17 PM EST
Madrigal Pharmaceuticals Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
| Revenue | 180.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 147K | 7.58M | 14.8M | 144.25M | 2.62M | 743K | n/a | n/a | 173K | 1.3M | n/a | n/a |
| Cost of Revenue | 6.23M | 527K | 467K | 405K | 471K | 112K | 96K | 77K | 156.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | 173.9M | -527K | -467K | -405K | -471K | -112K | -96K | -77K | -156 | n/a | n/a | n/a | 147K | 7.58M | 14.8M | 144.25M | 2.62M | 743K | n/a | n/a | 173K | 1.3M | n/a | n/a |
| Operating Income | -497.88M | -380.5M | -293.57M | -242.48M | -206.67M | -94.97M | -40.68M | -32.06M | -25.22M | -67.61M | -83.95M | -87.56M | -60.94M | -45.43M | -36.9M | 79.3M | -93.71M | -66.22M | -59.15M | -71.18M | -46.93M | -28.29M | -36.26M | -401K |
| Interest Income | 46.65M | 19.58M | 2.19M | 363K | 4.33M | 11.02M | 7.67M | 558K | 48.3K | n/a | n/a | n/a | n/a | n/a | n/a | 96K | 1.58M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -465.89M | -373.63M | -295.35M | -241.85M | -202.24M | -83.95M | -32.81M | -31.15M | -26.39M | -68.67M | -86.16M | -90.19M | -62.79M | -47.38M | -37.47M | 79.09M | -92.62M | -122.08M | -59.13M | -68.86M | -47.52M | -27.88M | -54.35M | n/a |
| Net Income | -465.89M | -373.63M | -299.31M | -241.08M | -197.44M | -72.81M | -32.81M | -31.15M | -26.39M | -68.67M | -86.16M | -90.19M | -62.79M | -47.38M | -37.47M | 79.09M | -92.62M | -63.49M | -57.27M | -68.86M | -45.93M | -27.88M | -36.15M | -381K |
| Selling & General & Admin | 435.06M | 108.15M | 48.13M | 37.32M | 21.86M | 22.65M | 15.29M | 7.67M | 9.29M | 13.39M | 15.75M | 15.7M | 11.68M | 11.55M | 11.45M | 12.65M | 14.74M | 14.93M | 8.65M | 11.28M | 7.38M | 5.26M | n/a | 124K |
| Research & Development | 236.72M | 271.82M | 245.44M | 205.16M | 184.81M | 72.32M | 25.39M | 24.39M | 15.93M | 54.22M | 68.2M | 71.86M | 49.41M | 41.46M | 40.25M | 51.05M | 81.58M | 52.02M | 50.5M | 59.9M | 38.14M | 24.34M | 7.29M | 277K |
| Other Expenses | n/a | n/a | n/a | 273K | 100K | n/a | 200K | 350K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 671.77M | 380.5M | 293.57M | 242.48M | 206.67M | 94.97M | 40.68M | 32.06M | 25.22M | 67.61M | 83.95M | 87.56M | 61.09M | 53.02M | 51.7M | 63.7M | 96.32M | 66.96M | 59.15M | 71.18M | 45.52M | 29.6M | 7.29M | 401K |
| Interest Expense | 14.67M | 12.71M | 3.96M | n/a | n/a | 11.02M | 7.67M | 558K | 1.16M | 1.06M | 2.21M | 2.63M | 1.85M | 1.95M | 569K | 312K | 489K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 678.01M | 380.5M | 293.57M | 242.48M | 206.67M | 94.97M | 40.68M | 32.06M | 25.22M | 67.61M | 83.95M | 87.56M | 61.09M | 53.02M | 51.7M | 63.7M | 96.32M | 66.96M | 59.15M | 71.18M | 45.52M | 29.6M | 7.29M | 401K |
| Income Tax | n/a | n/a | 3.96M | -768K | -4.8M | -11.14M | 7.87M | -635K | -373 | n/a | n/a | n/a | n/a | n/a | n/a | 1.45M | n/a | -2.72M | -1.88M | -2.32M | 588K | -416K | -18.2M | 381K |
| Shares Outstanding (Basic) | 21.27M | 18.69M | 17.14M | 16.54M | 15.45M | 15.39M | 14.8M | 12.24M | 5.2M | 171.01K | 2.81M | 2.03M | 1.7M | 1.35M | 1.15M | 968.21K | 963.86K | 927.59K | 636.14K | 635.8K | 534.39K | 624.37K | 344.04K | 83.73K |
| Shares Outstanding (Diluted) | 21.27M | 18.69M | 17.14M | 16.54M | 15.45M | 15.39M | 14.8M | 12.24M | 5.2M | 171.01K | 2.81M | 2.03M | 1.7M | 1.35M | 1.15M | 974.81K | 963.86K | 927.59K | 636.14K | 635.8K | 534.39K | 624.37K | 344.04K | 83.73K |
| EPS (Basic) | -21.9 | -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 | -2.54 | -5.07 | -401.56 | -30.62 | -44.48 | -36.99 | -35.14 | -32.49 | 81.55 | -96.09 | -68.45 | -90.03 | -108.31 | -85.96 | -44.65 | -105.09 | -4.55 |
| EPS (Diluted) | -21.9 | -19.99 | -17.47 | -14.58 | -12.78 | -4.73 | -2.22 | -2.54 | -5.07 | -401.56 | -30.62 | -44.48 | -36.99 | -35.14 | -32.49 | 81.20 | -96.09 | -68.45 | -90.03 | -108.31 | -85.96 | -44.65 | -105.09 | -4.55 |
| EBITDA | -450.13M | -379.97M | -293.1M | -242.08M | -206.2M | -94.86M | -40.59M | -31.98M | -22.52M | -3.23M | -83.28M | -87.04M | -60.2M | -43.97M | -34.97M | 81.86M | -90.99M | -62.87M | -53.62M | -71.04M | -43.8M | -27.29M | 10.8M | -401K |
| Depreciation & Amortization | 1.1M | 527K | 467K | 405K | 471K | 112K | 96K | 77K | 156.00 | 662K | 673K | 516K | 738K | 1.46M | 1.93M | 2.46M | 2.72M | 3.35M | 3.65M | 2.46M | 1.55M | 1.01M | 47.06M | n/a |